Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Callisia N Clarke

Showing results (51-60 of 95) with videos related to

Pageof 10
Sort By:
Annals of Surgical Oncology|October 24, 2019
Management of Acute Cholecystitis during Neoadjuvant Therapy in Patients with Pancreatic AdenocarcinomaNeil R Jariwalla, Abdul H Khan, Kulwinder Dua, et al.
Annals of Surgery|July 23, 2025
Association of Traditional and new Surgical Wait Time Targets and Survival for Curative-intent Colorectal Cancer Surgery: A Population-based Cohort StudyAdom Bondzi-Simpson, Rinku Sutradhar, Frances C Wright, et al.
Journal of the American College of Surgeons|April 22, 2017
Prognostic Scoring System to Risk Stratify Parathyroid CarcinomaAngelica M Silva-Figueroa, Kenneth R Hess, Michelle D Williams, et al.
Annals of Surgical Oncology|October 1, 2020
Total Neoadjuvant Therapy for Operable Pancreatic CancerRebecca Y Kim, Kathleen K Christians, Mohammed Aldakkak, et al.
International Journal of Surgery (London, England)|May 24, 2016
Parathyroid carcinoma and atypical parathyroid neoplasms in MEN1 patients; A clinico-pathologic challenge. The MD Anderson case series and review of the literatureIoannis Christakis, Naifa L Busaidy, Gilbert J Cote, et al.
Journal of Surgical Oncology|March 24, 2023
Neoadjuvant chemotherapy for pancreatic cancer: Quality over quantitySam Z Thalji, Mohammed Aldakkak, Kathleen K Christians, et al.
Journal of Women'S Health (2002)|November 27, 2023
Can I Leave? Perspectives on Parental Leave and Parenthood in Medical Training Among Program Directors and Trainees in Oncologic SpecialtiesSara Beltrán Ponce, Reshma Jagsi, Narjust Florez, et al.
Annals of Surgical Oncology|February 14, 2023
CA19-9 Response to First-Line Neoadjuvant FOLFIRINOX and Second-Line Gemcitabine/Nab-Paclitaxel for Patients with Operable Pancreatic CancerSam Z Thalji, Mandana Kamgar, Ben George, et al.
Journal of Surgical Oncology|June 20, 2020
Retroperitoneal sarcoma perioperative risk stratification: A United States Sarcoma Collaborative evaluation of the ACS-NSQIP risk calculatorPatrick B Schwartz, Christopher C Stahl, Cecilia Ethun, et al.
Surgery|July 10, 2020
Radiographic patterns of first disease recurrence after neoadjuvant therapy and surgery for patients with resectable and borderline resectable pancreatic cancerChad A Barnes, Mohammed Aldakkak, Kathleen K Christians, et al.
Pageof 10

Showing results (51-60 of 95) with videos related to

Sort By:
Pageof 10
Annals of Surgical Oncology|October 24, 2019
Management of Acute Cholecystitis during Neoadjuvant Therapy in Patients with Pancreatic AdenocarcinomaNeil R Jariwalla, Abdul H Khan, Kulwinder Dua, et al.
Annals of Surgery|July 23, 2025
Association of Traditional and new Surgical Wait Time Targets and Survival for Curative-intent Colorectal Cancer Surgery: A Population-based Cohort StudyAdom Bondzi-Simpson, Rinku Sutradhar, Frances C Wright, et al.
Journal of the American College of Surgeons|April 22, 2017
Prognostic Scoring System to Risk Stratify Parathyroid CarcinomaAngelica M Silva-Figueroa, Kenneth R Hess, Michelle D Williams, et al.
Annals of Surgical Oncology|October 1, 2020
Total Neoadjuvant Therapy for Operable Pancreatic CancerRebecca Y Kim, Kathleen K Christians, Mohammed Aldakkak, et al.
International Journal of Surgery (London, England)|May 24, 2016
Parathyroid carcinoma and atypical parathyroid neoplasms in MEN1 patients; A clinico-pathologic challenge. The MD Anderson case series and review of the literatureIoannis Christakis, Naifa L Busaidy, Gilbert J Cote, et al.
Journal of Surgical Oncology|March 24, 2023
Neoadjuvant chemotherapy for pancreatic cancer: Quality over quantitySam Z Thalji, Mohammed Aldakkak, Kathleen K Christians, et al.
Journal of Women'S Health (2002)|November 27, 2023
Can I Leave? Perspectives on Parental Leave and Parenthood in Medical Training Among Program Directors and Trainees in Oncologic SpecialtiesSara Beltrán Ponce, Reshma Jagsi, Narjust Florez, et al.
Annals of Surgical Oncology|February 14, 2023
CA19-9 Response to First-Line Neoadjuvant FOLFIRINOX and Second-Line Gemcitabine/Nab-Paclitaxel for Patients with Operable Pancreatic CancerSam Z Thalji, Mandana Kamgar, Ben George, et al.
Journal of Surgical Oncology|June 20, 2020
Retroperitoneal sarcoma perioperative risk stratification: A United States Sarcoma Collaborative evaluation of the ACS-NSQIP risk calculatorPatrick B Schwartz, Christopher C Stahl, Cecilia Ethun, et al.
Surgery|July 10, 2020
Radiographic patterns of first disease recurrence after neoadjuvant therapy and surgery for patients with resectable and borderline resectable pancreatic cancerChad A Barnes, Mohammed Aldakkak, Kathleen K Christians, et al.
Pageof 10